Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 14;38(5):722-731.
doi: 10.1080/08998280.2025.2524792. eCollection 2025.

Racial disparities in non-small cell lung cancer survival outcomes: a systematic review and meta-analysis

Chalothorn Wannaphut  1 , Ben Ponvilawan  2 , Chanakarn Kanitthamniyom  3 , Pojsakorn Danpanichkul  3 , Narathorn Kulthamrongsri  1 , Vitchapong Prasitsumrit  4 , Phuuwadith Wattanachayakul  5   6 , Sakditad Saowapa  3
Affiliations

Racial disparities in non-small cell lung cancer survival outcomes: a systematic review and meta-analysis

Chalothorn Wannaphut et al. Proc (Bayl Univ Med Cent). .

Abstract

Background: Previous studies have demonstrated disparities in survival outcomes between Black/African American, Asian, and White patients with non-small cell lung cancer (NSCLC). Some studies have suggested that non-White patients have poorer survival outcomes due to socioeconomic factors, while others have reported different findings. Therefore, we performed a comprehensive review and meta-analysis to evaluate the impact of racial disparity on NSCLC survival outcomes.

Method: PubMed, Ovid MEDLINE, Embase, and Google Scholar were searched for articles published until September 2024. Eligible studies with aligned research objectives were included. Two reviewers independently extracted data. Methodological quality was assessed using the Newcastle-Ottawa Scale. The meta-analysis adhered to the PRISMA guidelines.

Result: Fifteen studies with 763,314 patients met the eligibility criteria. Asian and Asian/Pacific Islander (API) patients had significantly better overall survival (OS) compared to White patients (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.79-0.94; P < 0.01 and HR, 0.80; 95% CI, 0.69-0.93; P < 0.01, respectively). In contrast, OS differences were not statistically significant between Black and White (HR, 1.00; 95% CI, 0.94-1.07; P < 0.01) or Hispanic and White patients (HR, 0.93; 95% CI, 0.87-1.00; P = 0.19). Further, the subgroup analyses did not demonstrate any significant difference in OS outcome in any stage when comparing Black to White patients (stage I HR, 1.11; 95% CI, 1.00-1.23; P < 0.01; stage II HR, 1.03; 95% CI, 0.96-1.10; P = 0.26; stage III HR, 1.04; 95% CI, 0.96-1.12; P < 0.01; and stage IV HR, 1.02; 95% CI, 0.97-1.07; P < 0.01).

Conclusion: Asian and API patients with NSCLC exhibited superior OS outcomes compared to White patients. In contrast, racial disparities in survival outcomes were statistically insignificant for Black and Hispanic patients. Additionally, staging disparities in OS were not observed between Black and White patients with NSCLC.

Keywords: Genomic alterations; NSCLC; meta-analysis; racial disparities; survival outcome.

PubMed Disclaimer

Conflict of interest statement

The authors report no funding or conflicts of interest.

Figures

Figure 1.
Figure 1.
PRISMA diagram summary for the literature search.
Figure 2.
Figure 2.
Forest plots of the meta-analyses in (a) Asian vs White, (b) API vs White, (c) Black vs White, and (d) Hispanic vs White patients with non–small cell lung cancer.
Figure 3.
Figure 3.
Funnel plots of the meta-analyses in (a) Asian vs White, (b) API vs White, (c) Black vs White, and (d) Hispanic vs White patients with non–small cell lung cancer.
Figure 4.
Figure 4.
Forest plots of the meta-analyses in Black vs White patients with (a) stage I, (b) stage II, (c) stage III, and (d) stage IV non–small cell lung cancer.
Figure 5.
Figure 5.
Funnel plots of the meta-analyses in Black vs White patients with (a) stage I, (b) stage II, (c) stage III, and (d) stage IV non–small cell lung cancer.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Siegel RL, Miller KD, Wagle NS, Jemal A.. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. doi: 10.3322/caac.21763. - DOI - PubMed
    1. American Cancer Society . What is lung cancer? Types of lung cancer. Last revised January 2024. https://www.cancer.org/cancer/types/lung-cancer/about/what-is.html.
    1. Soneji S, Tanner NT, Silvestri GA, Lathan CS, Black W.. Racial and ethnic disparities in early stage lung cancer survival. Chest. 2017;152(3):587–597. doi: 10.1016/j.chest.2017.03.059. - DOI - PMC - PubMed
    1. Cheng E, Soulos PR, Irwin ML, et al. Neighborhood and individual socioeconomic disadvantage and survival among patients with nonmetastatic common cancers. JAMA Netw Open. 2021;4(12):e2139593. doi: 10.1001/jamanetworkopen.2021.39593. - DOI - PMC - PubMed
    1. Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL.. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol. 2018;36(1):25–33. doi: 10.1200/JCO.2017.74.2049. - DOI - PMC - PubMed

LinkOut - more resources